ID: ALA4871921
Max Phase: Preclinical
Molecular Formula: C27H34N2O5
Molecular Weight: 466.58
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=C1CC[C@@H]2[C@](C)(CNCc3ccc([N+](=O)[O-])cc3)[C@H](O)CC[C@@]2(C)[C@@H]1/C=C/C1=CCOC1=O
Standard InChI: InChI=1S/C27H34N2O5/c1-18-4-11-23-26(2,22(18)10-7-20-13-15-34-25(20)31)14-12-24(30)27(23,3)17-28-16-19-5-8-21(9-6-19)29(32)33/h5-10,13,22-24,28,30H,1,4,11-12,14-17H2,2-3H3/b10-7+/t22-,23+,24-,26+,27+/m1/s1
Standard InChI Key: MSWKCAPJVDZHBO-PNSMVNCNSA-N
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 466.58 | Molecular Weight (Monoisotopic): 466.2468 | AlogP: 4.47 | #Rotatable Bonds: 7 |
| Polar Surface Area: 101.70 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.54 | CX Basic pKa: 8.89 | CX LogP: 4.37 | CX LogD: 2.87 |
| Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.27 | Np Likeness Score: 1.85 |
References
| 1. Zhang S, Zhang Y, Fang Y, Chen H, Hao M, Tan Q, Hu C, Zhou H, Xu J, Gu Q.. (2021) Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo., 213 [PMID:33485256] [10.1016/j.ejmech.2021.113185] |
Source
Source(1):